Literature DB >> 11916073

Fibrinogen, viscosity and white blood cell count predict myocardial, but not cerebral infarction: evidence from the Caerphilly and Speedwell cohort.

Ian A Baker1, Janet Pickering, Peter C Elwood, Antony Bayer, Shah Ebrahim.   

Abstract

Fibrinogen, plasma viscocity, and the white blood cell count predict ischaemic heart disease, but there is less certainty for their predictive power for ischaemic stroke. Studying stroke and ischaemic heart disease in the same cohort prospectively allows comparison of predictive strengths. The Caerphilly and Speedwell cohorts consist of a population sample of 4,860 men aged 45-59 years at recruitment who had baseline measurements of fibrinogen, plasma viscosity, and white blood cell counts. After 15-19 years of follow-up, men in the two cohorts experienced 312 ischaemic strokes and 557 ischaemic heart disease events. Mean fibrinogen, plasma viscosity and white blood cell counts differed significantly after adjustment for confounding factors between men with and without ischaemic heart disease, 0.25 g/l (95% CIs 0.1 8-0.32); 0.036 cp (95% CIs 0.027-0.044); 0.67 x 10(9)/l (95% CIs 0.50-0.84) respectively. The same measurements showed no significant differences after adjustment for the same confounding factors for men with and without ischaemic stroke, 0.05 g/l (95% CIs -0.04-0.14); 0.008 cp (95% CIs -0.003-0.019); 0.16 x 10(9)/l (95% CIs -0.06-0.38) respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11916073

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort.

Authors:  Peter Elwood; Melissa Hack; Janet Pickering; Janie Hughes; John Gallacher
Journal:  J Epidemiol Community Health       Date:  2006-01       Impact factor: 3.710

2.  Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.

Authors:  H S Gurm; D L Bhatt; A M Lincoff; J E Tcheng; D J Kereiakes; N S Kleiman; G Jia; E J Topol
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

3.  Changes of Hematological and Hemorheological Parameters in Rabbits with Hypercholesterolemia.

Authors:  Bence Tanczos; Viktoria Somogyi; Mariann Bombicz; Bela Juhasz; Norbert Nemeth; Adam Deak
Journal:  Metabolites       Date:  2021-04-17

4.  Dairy Foods and Body Mass Index over 10-Year: Evidence from the Caerphilly Prospective Cohort Study.

Authors:  Jing Guo; Anestis Dougkas; Peter C Elwood; David I Givens
Journal:  Nutrients       Date:  2018-10-16       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.